Characteristics of Suicides and Toxicology in a Cohort of Individuals With Opioid Use Disorder

REFERENCES

• Ahmadi, J., Jahromi, M. S., & Ehsaei, Z. (2018). The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: A randomized, double-blind, clinical trial. Trials, 19(1), 462. doi:10.1186/s13063-018-2843-9
   PubMed Web of Science ®Google Scholar
• Austin, A. E., Proescholdbell, S. K., Creppage, K. E., & Asbun, A. (2017). Characteristics of self-inflicted drug overdose deaths in North Carolina. Drug and Alcohol Dependence, 181, 44–49. doi:10.1016/j.drugalcdep.2017.09.014
   PubMed Web of Science ®Google Scholar
• Bachmann, S. (2018). Epidemiology of suicide and the psychiatric perspective. International Journal of Environmental Research and Public Health, 15(7), 1425. doi:10.3390/ijerph15071425
   PubMed Web of Science ®Google Scholar
• Bohnert, A. S. B., & Ilgen, M. A. (2019). Understanding links among opioid use, overdose, and suicide N. The New England Journal of Medicine, 380, 71–79. doi:10.1056/NEJMra1802148
   PubMed Web of Science ®Google Scholar
• Bohnert, K. M., Ilgen, M. A., Louzon, S., McCarthy, J. F., & Katz, I. R. (2017). Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration. Addiction, 112, 1193–1201. doi:10.1111/add.13774
   PubMed Web of Science ®Google Scholar
• Braden, J. B., Edlund, M. J., & Sullivan, M. D. (2017). Suicide deaths with opioid poisoning in the United States: 1999–2014. American Journal of Public Health, 107, 421–426. doi:10.2105/AJPH.2016.303591
   PubMed Web of Science ®Google Scholar
• Canetto, S. S., & Sakinofsky, I. (1998). The gender paradox in suicide. Suicide Life Threatening Behavior, 28, 1–23.
   PubMed Web of Science ®Google Scholar
• Chan, E. Y. L., McDonald, B. M., Brooks-Lim, E., Jones, G. R., Klein, K. B., & Svenson, L. W. (2018). The role of opioid toxicity in suicide deaths in Alberta, 2000–2016. Health Promotion and Chronic Disease Prevention in Canada, 38, 343–347. doi:10.24095/hpcdp.38.9.07
   PubMed Web of Science ®Google Scholar
• Coplan, P. M., Sessler, N. E., Harikrishnan, V., Singh, R., & Perkel, C. (2017). Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System. Postgraduate Medical Journal, 129, 55–61. doi:10.1080/00325481.2017.1269596
   Google Scholar
• Darke, S., & Ross, J. (2002). Suicide among heroin users: Rates, risk factors and methods. Addiction, 97, 1383–1394. doi:10.1046/j.1360-0443.2002.00214.x
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Charlson, F., Ferrari, A., Santomauro, D., Erskine, H., Mantilla-Herrara, A., … Vos, T. (2018). The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Psychiatry, 5(12), 987–1012. doi:10.1016/S2215-0366(18)30337-7
   PubMed Web of Science ®Google Scholar
• Demidenko, M. I., Dobscha, S.K., Morasco, B. J., Meath, T. H. A., Ilgen, M. A., & Lovejoy, T. I. (2017). Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users. General Hospital Psychiatry, 47, 29–35. doi:10.1016/j.genhosppsych.2017.04.011
   PubMed Web of Science ®Google Scholar
• Denning, D. G., Conwell, Y., King, D., & Cox, C. (2000). Method choice, intent, and gender in completed suicide. Suicide and Life-Threatening Behavior, 30, 282–288.
   PubMed Web of Science ®Google Scholar
• Engtsrom, A., Adamsson, C. M., Allebeck, P., & Rydberg, W. (1991). Mortality in patients with substance abuse: A follow-up in Stockholm County, 1973–84. International Journal of the Addictions, 26, 91–106. doi:10.3109/10826089109056241
   PubMedGoogle Scholar
• Gauthier, S., Reisch, T., & Bartsch, C. (2015). Swiss prison suicides between 2000 and 2010. Crisis, 36, 110–116. doi:10.1027/0227-5910/a000302
   PubMedGoogle Scholar
• Gjelsvik, B., Heyerdahl, F., & Hawton, K. (2012). Prescribed medication availability and deliberate self-poisoning: A longitudinal study. The Journal of Clinical Psychiatry, 73, e548–e554. doi:10.4088/JCP.11m07209
   PubMedGoogle Scholar
• Habenstein, A., Steffen, T., Bartsch, C., Michaud, K., & Reisch, T. (2013). Chances and limits of method restriction: A detailed analysis of suicide methods in Switzerland. Archives of Suicide Research, 17, 75–87. doi:10.1080/13811118.2013.748418
   PubMed Web of Science ®Google Scholar
• Halbert, B. T., Davis, R. B., & Wee, C. C. (2016). Disproportionate longer-term opioid use among U.S. adults with mood disorders. Pain, 157, 2452–2457. doi:10.1097/j.pain.0000000000000650
   PubMed Web of Science ®Google Scholar
• Hawton, K., Bergen, H., Simkin, S., Cooper, J., Waters, K., Gunnell, D., & Kapur, N. (2010). Toxicity of antidepressants: Rates of suicide relative to prescribing and non-fatal overdose. British Journal of Psychiatry, 196, 354–358. doi:10.1192/bjp.bp.109.070219
   PubMed Web of Science ®Google Scholar
• Ilgen, M. A., Bohnert, A. S., Ganoczy, D., Bair, M. J., Carthy, J. F., & Blow, F. C. (2016). Opioid dose and risk of suicide. Pain, 157, 1079–1084. doi:10.1097/j.pain.0000000000000484
   PubMed Web of Science ®Google Scholar
• Laberke, P. J., & Bartsch, C. (2010). Trends in methadone-related deaths in Zurich. International Journal of Legal Medicine, 124, 381–385. doi:10.1007/s00414-010-0442-8
   PubMed Web of Science ®Google Scholar
• Nordt, C., Caflisch, C., & Herdener, M. (2015). Morphin in der Substitutionsbehandlung: Verbreitung und Auswirkung auf substitutionsgestützte Behandlungen. Psychiatrische Universitätsklinik Zürich, Forschungsgruppe Substanzstörungen, 21, 1–4.
   Google Scholar
• Oquendo, M. A., & Volkow, N. D. (2018). Suicide: A silent contributor to opioid-overdose deaths. New England Journal of Medicine, 378, 1567–1569. doi:10.1056/NEJMp1801417
   PubMed Web of Science ®Google Scholar
• Pfeifer, P., Bartsch, C., Hemmer, A., & Reisch, T. (2017). Acute and chronic alcohol use correlated with methods of suicide in a Swiss national sample. Drug and Alcohol Dependence, 178, 75–79. doi:10.1016/j.drugalcdep.2017.05.009
   PubMed Web of Science ®Google Scholar
• Rossow, I., & Lauritzen, G. (1999). Balancing on the edge of death: Suicide attempts and life-threatening overdoses among drug addicts. Addiction, 94, 209–219. doi:10.1046/j.1360-0443.1999.9422095.x
   PubMed Web of Science ®Google Scholar
• Scherrer, J. F., Svrakic, D. M., Freedland, K. E., Chrusciel, T., Balasubramanian, S., Bucholz, K. K., … Lustman, P. J. (2014). Prescription opioid analgesics increase the risk of depression. Journal of General Internal Medicine, 29, 491–499. doi:10.1007/s11606-013-2648-1
   PubMed Web of Science ®Google Scholar
• Stone, D. M., Holland, K. M., Bartholow, B., Logan, E., LiKamWa McIntosh, W., Trudeau, A., & Rockett, I. R. H. (2017). Deciphering suicide and other manners of death associated with drug intoxication: A Centers for Disease Control and Prevention consultation meeting summary. American Journal of Public Health, 107, 1233–1239. doi:10.2105/AJPH.2017.303863
   PubMed Web of Science ®Google Scholar
• Swiss Statistics of Substitution Treatment. (2018). https://www.substitution.ch/de/jahrliche_statistik.htmlyear=2018&trend
   Google Scholar
• Turner, B. J., & Liang, Y. (2015). Drug overdose in a retrospective cohort with non-cancer pain treated with opioids, antidepressants, and/or sedative-hypnotics: Interactions with mental health disorders. Journal of General Internal Medicine, 30, 1081–1096. doi:10.1007/s11606-015-3199-4
   PubMed Web of Science ®Google Scholar
• Wilcox, H. C., Conner, K. R., & Caine, E. D. (2004). Association of alcohol and drug use disorders and completed suicide: An empirical review of cohort studies. Drug and Alcohol Dependence., 76(Suppl), S11–S9. doi:10.1016/j.drugalcdep.2004.08.003
   PubMed Web of Science ®Google Scholar